Other languages Maccura Biotechnology Co.Ltd

Equities

300463

CNE1000020H3

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
12.91 ^CNY	+0.23%		-0.69%	-14.33%

Apr. 25	Maccura Biotechnology Co.Ltd Proposes Final Cash Dividend for the Year 2023	CI
Apr. 24	Maccura Biotechnology Co.Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Maccura Biotechnology Co.Ltd Proposes Final Cash Dividend for the Year 2023	Apr. 24
Maccura Biotechnology Co.Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 24
Maccura Biotechnology Co.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24
Tranche Update on Maccura Biotechnology Co.Ltd's Equity Buyback Plan announced on February 6, 2024.	Apr. 01
Maccura Biotechnology Co.Ltd announces an Equity Buyback for CNY 100 million worth of its shares.	Feb. 05
Maccura Biotechnology Co.Ltd authorizes a Buyback Plan.	Feb. 04
Maccura Biotechnology Co.Ltd(SZSE:300463) dropped from Shenzhen Stock Exchange Component A Share Index	Dec. 11
Maccura Biotechnology Co.Ltd(SZSE:300463) dropped from Shenzhen Stock Exchange Component Index	Dec. 11
Maccura Biotechnology Co.Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25
Maccura Biotechnology Registers Infectious Disease Diagnosis Kit	23-08-04
Maccura Biotechnology Co.Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-28
Maccura Biotechnology Co.Ltd Approves Cash Dividend for 2022, Payable on May 29, 2023	23-05-16
Maccura Biotechnology Co.Ltd Proposes Final Cash Dividend for 2022	23-04-25
Maccura Biotechnology Co.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-24
Maccura Biotechnology Co.Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-24
Maccura Biotechnology Co.Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-24
Maccura Biotechnology Co.Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-07-15
Mega Genomics Braves Market Turbulence, Raises $19.5 Million in Hong Kong IPO	22-06-20
Mega Genomics Braves Market Turbulence with Launch of $34 Million Hong Kong IPO	22-06-10
DMaccura Biotechnology Co.Ltd Approves Cash Dividend for 2021, Payable on May 19, 2022	22-05-13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Maccura Biotechnology Co.Ltd

Equities

300463

CNE1000020H3

Other languages

Filters